<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05084248</url>
  </required_header>
  <id_info>
    <org_study_id>STU-2019-1223</org_study_id>
    <nct_id>NCT05084248</nct_id>
  </id_info>
  <brief_title>Vitamin D Deficiency in Adults Following a Major Burn Injury</brief_title>
  <official_title>Vitamin D Deficiency in Adults Following a Major Burn Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single site double blind randomized controlled trial of replacing Vitamin D for&#xD;
      Vitamin D-deficient burn patients at a current recommended dose (400 IU daily) versus a&#xD;
      higher dose (4000 IU daily). Capsules will be made in a compounding pharmacy and will look&#xD;
      identical.&#xD;
&#xD;
      Randomized controlled trial. People who meet the selection criteria will be randomized to&#xD;
      either low or high dosage of Vitamin D. Treatment arm is high dose Vitamin D (4000 IU), and&#xD;
      control is low dose Vitamin D (400 IU). Main outcome variables include PROMIS-29 measures of&#xD;
      physical health, mental health and social health, the Veterans RAND 12 Item Health Survey&#xD;
      (VR-12), and the 4-D Itch Scale. Secondary outcome variables include subject demographics,&#xD;
      injury demographics and characteristics.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">February 2024</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient-Reported Outcomes Measurement Information System-29</measure>
    <time_frame>6 months</time_frame>
    <description>Measures of physical health, mental health and social health</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Demographics</measure>
    <time_frame>6 months</time_frame>
    <description>include subject demographics, injury demographics and characteristics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Veterans Research And Development-12 Item Health Survey (VR-12)</measure>
    <time_frame>6 months</time_frame>
    <description>Measures of emotional, physical, and social health</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4-D Itch Scale</measure>
    <time_frame>6 months</time_frame>
    <description>Measure of itch</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Low-dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>400 IU Per Orem</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High-dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4000 IU Per Orem</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ergocalciferol Capsules</intervention_name>
    <description>Capsules of ergocalciferol at 400 IU and 4000 IU</description>
    <arm_group_label>High-dose</arm_group_label>
    <arm_group_label>Low-dose</arm_group_label>
    <other_name>Vitamin D</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults, 18 years of age or older, who have completed 6 months from time of their burn&#xD;
             injury&#xD;
&#xD;
          2. ≥ 10% TBSA, ≥ 65 years of age and Burn Surgery for Wound Closure&#xD;
&#xD;
          3. ≥ 20% TBSA, 18 - 64 of age and Burn Surgery for Wound Closure&#xD;
&#xD;
          4. Electrical high voltage / lightning and Burn Surgery for Wound Closure&#xD;
&#xD;
          5. Hand burn and/or face burn, and/or feet burn and Burn Surgery for Wound Closure&#xD;
&#xD;
          6. May speak English or Spanish&#xD;
&#xD;
          7. Vit. D deficiency&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with parathyroid disease, severe liver dysfunction, sever kidney dysfunction,&#xD;
             which are not caused by the burn injury&#xD;
&#xD;
          2. Patients with malignant tumors&#xD;
&#xD;
          3. Patients not meeting the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Pia Kabamalan</last_name>
    <role>Study Chair</role>
    <affiliation>UT Southwestern</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anita Oladunni, MS</last_name>
    <phone>214-648-3654</phone>
    <email>Anita.oladunni@utsouthwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karen Kowalske, MD</last_name>
    <phone>214-645-2080</phone>
    <email>karen.kowalske@utsouthwestern.edu</email>
  </overall_contact_backup>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 27, 2021</study_first_submitted>
  <study_first_submitted_qc>October 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Karen Kowalske</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Data may be shared with Burn Model System under National Institute on Disability and Rehabilitation Research.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

